相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic drug monitoring of antimicrobials
Jason A. Roberts et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients Association Between Augmented Renal Clearance and Low Trough Drug Concentrations
Andrew A. Udy et al.
CHEST (2012)
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: A multicentre pharmacokinetic study
Darren M. Roberts et al.
CRITICAL CARE MEDICINE (2012)
Continuous infusion of piperacillin/tazobactam in ventilator-associated pneumonia: a pilot study on efficacy and costs
Wieslawa Duszynska et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study
Janice Li et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Burns Patients-A One-Year Prospective Study
Bhavik M. Patel et al.
THERAPEUTIC DRUG MONITORING (2012)
Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials
Pranita D. Tamma et al.
BMC INFECTIOUS DISEASES (2011)
Neurotoxic effects associated with antibiotic use: management considerations
Marie F. Grill et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Antibiotic Dosing in Multiple Organ Dysfunction Syndrome
Marta Ulldemolins et al.
CHEST (2011)
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
Marta Ulldemolins et al.
CLINICAL PHARMACOKINETICS (2011)
Antimicrobial Pharmacokinetic and Pharmacodynamic Issues in the Critically Ill with Severe Sepsis and Septic Shock
Julie M. Varghese et al.
CRITICAL CARE CLINICS (2011)
Sustained low efficiency dialysis allows rational renal replacement therapy, but does it allow rational drug dosing?
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2011)
Revisiting Beta-lactams - PK/PD improves dosing of old antibiotics
Alasdair MacGowan
CURRENT OPINION IN PHARMACOLOGY (2011)
Editorial [Hot Topic: Relevance of Pharmacokinetics to Antibiotic Dosing in Critically Ill Patients (Guest Editor: Jason A. Roberts)]
Jason A. Roberts
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Using PK/PD to Optimize Antibiotic Dosing for Critically Ill Patients
Jason A. Roberts
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams
Joao Goncalves-Pereira et al.
CRITICAL CARE (2011)
High-Dose Continuous Infusion β-Lactam Antibiotics for the Treatment of Resistant Pseudomonas aeruginosa Infections in Immunocompromised Patients
Brad Moriyama et al.
ANNALS OF PHARMACOTHERAPY (2010)
Identification of Optimal Renal Dosage Adjustments for Traditional and Extended-Infusion Piperacillin-Tazobactam Dosing Regimens in Hospitalized Patients
N. Patel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa
Jared L. Crandon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration
I. Bilgrami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Scenario 1: A Patient with Hospital-Acquired Bacterial Pneumonia-Introduction to Clinical Trial Design Issues
David N. Gilbert
CLINICAL INFECTIOUS DISEASES (2010)
Challenges in the Design and Conduct of Clinical Trials for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: An Industry Perspective
Steven L. Barriere
CLINICAL INFECTIOUS DISEASES (2010)
Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill
Andrew A. Udy et al.
CLINICAL PHARMACOKINETICS (2010)
Augmented renal clearance in the Intensive Care Unit: an illustrative case series
Andrew A. Udy et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Daily serum piperacillin monitoring is advisable in critically ill patients
Nicolas Blondiaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Determination of antibiotic dosage adjustments in patients with renal impairment: elements for success
Nimish Patel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Adjustment of dosing of antimicrobial agents for bodyweight in adults
Matthew E. Falagas et al.
LANCET (2010)
Prospective Determination of Serum Ceftazidime Concentrations in Intensive Care Units
Gerald Aubert et al.
THERAPEUTIC DRUG MONITORING (2010)
Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock
Fabio Silvio Taccone et al.
CRITICAL CARE (2010)
Prospective monitoring of cefepime in intensive care unit adult patients
Thomas M. Chapuis et al.
CRITICAL CARE (2010)
Pharmacokinetic issues for antibiotics in the critically ill patient
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
Piperacillin penetration into tissue of critically ill patients with sepsis-Bolus versus continuous administration?
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
A systematic review on clinical benefits of continuous administration of β-lactam antibiotics
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections
Gita Wasan Patel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
Leonardo Lorente et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Comparison of the pharmacodynamics of imipenem in patients with ventilator-associated pneumonia following administration by 2 or 0.5 h infusion
Sutep Jaruratanasirikul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Antibiotic resistance - What's dosing got to do with it?
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2008)
Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study
Jean Chastre et al.
CRITICAL CARE MEDICINE (2008)
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2008)
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Peggy S. McKinnon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
The neurotoxicity and safety of treatment with cefepime in patients with renal failure
J. Sonck et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection
Raf De Jongh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion:: A retrospective, nonrandomized, open-label, historical chart review
Leonardo Lorente et al.
CLINICAL THERAPEUTICS (2007)
Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections:: Prolonged or continuous infusion?
Aryun Kim et al.
PHARMACOTHERAPY (2007)
Continuous infusion of beta-lactams
Johan W. Mouton et al.
CURRENT OPINION IN CRITICAL CARE (2007)
Antimicrobial dosing considerations in obese adult patients - Insights from the society of infectious diseases pharmacists
Manjunath P. Pai et al.
PHARMACOTHERAPY (2007)
Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections
Chonghua Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Cefepime pharmacodynamics in patients with extended spectrum β-lactamase (ESBL) and non-ESBL infections
Su Young Lee et al.
JOURNAL OF INFECTION (2007)
Piperacillin-tazobactam for Pseudomonas aeruginosa infection:: Clinical implications of an extended-infusion dosing strategy
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2007)
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial
Samir G. Sakka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection
William K. Lau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Drug therapy: Management of sepsis
Jarnes A. Russell
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients
Mohammad Reza Rafati et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Cefepime neurotoxicity: Case report, pharmacokinetic considerations, and literature review
Sum Lam et al.
PHARMACOTHERAPY (2006)
Sepsis in European intensive care units: Results of the SOAP study
JL Vincent et al.
CRITICAL CARE MEDICINE (2006)
Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli
L Lorente et al.
ANNALS OF PHARMACOTHERAPY (2006)
Antibacterial dosing in intensive care - Pharmacokinetics, degree of disease and pharmacodynamics of sepsis
Jason A. Roberts et al.
CLINICAL PHARMACOKINETICS (2006)
Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside
KM Chow et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection
S Jaruratanasirikul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa?: An in vitro pharmacodynamic model
L Alou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Continuous versus intermittent intravenous administration of antibacterials with time-dependent action - A systematic review of pharmacokinetic and pharmacodynamic parameters
SK Kasiakou et al.
DRUGS (2005)
Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials
SK Kasiakou et al.
LANCET INFECTIOUS DISEASES (2005)
Pharmacokinetics and pharmacodynamics of meropenern in febrile neutropenic patients with bacteremia
RE Ariano et al.
ANNALS OF PHARMACOTHERAPY (2005)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia
E Boselli et al.
INTENSIVE CARE MEDICINE (2004)
Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model:: effect of combination with tobramycin simulating human serum pharmacokinetics
D Navas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid
WA Craig
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units
N Baririan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Retrospective review of neurotoxicity induced by cefepime and ceftazidime
KM Chow et al.
PHARMACOTHERAPY (2003)
Prevention of resistance: A goal for dose selection for antimicrobial agents
GL Drusano
CLINICAL INFECTIOUS DISEASES (2003)
Pharmacodynamics of cefepime in patients with Gram-negative infections
VH Tam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Comparative stability studies of antipseudomonal β-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units)
E Viaene et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections
SLCE Buijk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients
H Servais et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
DP Nicolau et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model
MA Robaux et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Intermittent and continuous ceftazidime infusion for critically ill trauma patients
SD Hanes et al.
AMERICAN JOURNAL OF SURGERY (2000)
分享论文
